keyword
https://read.qxmd.com/read/38088340/-mimosa-pudica-linn-extract-improves-aphrodisiac-performance-in-diabetes-induced-male-wister-rats
#41
JOURNAL ARTICLE
Chandrasekar Palanichamy, Damodar Nayak Ammunje, Parasuraman Pavadai, Sureshbabu Ram Kumar Pandian, Panneerselvam Theivendren, Shanmugampillai Jeyarajaguru Kabilan, Ewa Babkiewicz, Piotr Maszczyk, Selvaraj Kunjiappan
Male sexual dysfunction is considered one of the major consequences of diabetes mellitus. The medicinal plant, Mimosa pudica Linn. is believed to have numerous therapeutic effects, including anti-diabetic, anti-obesity, aphrodisiac, and a sexual behaviour-enhancing properties. In the present study, the significant effect of ethanolic extract of M. pudica L. to scavenge excessive free radicals and alleviate the deleterious effects of alloxan-induced diabetes on the male sexual system of rats was demonstrated...
December 13, 2023: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38086555/a-drug-target-for-erectile-dysfunction-to-help-improve-fertility-sexual-activity-and-wellbeing-mendelian-randomisation-study
#42
JOURNAL ARTICLE
Benjamin Woolf, Skanda Rajasundaram, Héléne T Cronjé, James Yarmolinsky, Stephen Burgess, Dipender Gill
OBJECTIVE: To investigate the association of genetically proxied (using a surrogate biomarker) inhibition of phosphodiesterase 5 (PDE5), an established drug target for erectile dysfunction, with fertility, sexual behaviour, and subjective wellbeing. DESIGN: Two sample cis-mendelian randomisation study. SETTING: Summary data on genetic associations obtained from the International Consortium for Blood Pressure and UK Biobank. PARTICIPANTS: Individuals of European ancestry from the International Consortium for Blood Pressure (n=757 601) for estimating PDE5 inhibition (using the surrogate biomarker of diastolic blood pressure reduction), and UK Biobank (n=211 840) for estimating the fertility, sexual behaviour, and subjective wellbeing outcomes in male participants...
December 12, 2023: BMJ: British Medical Journal
https://read.qxmd.com/read/38060834/identifying-phosphodiesterase-5-inhibitors-with-drug-repurposing-approach-implications-in-vasodysfunctional-disorders
#43
JOURNAL ARTICLE
Mohd Shahnawaz Khan, Hamza Ahmad Mohammad, Moyad Shahwan, Dharmendra Kumar Yadav, Saleha Anwar, Anas Shamsi
Phosphodiesterase type 5 (PDE5) is a multidomain protein that plays a crucial role in regulating cellular cyclic guanosine monophosphate (cGMP), a key signaling molecule involved in various physiological processes. Dysregulation of PDE5 and cGMP signaling is associated with a range of vasodysfunctional disorders, necessitating the development of effective therapeutic interventions. This study adopts comprehensive approach, combining virtual screening and molecular dynamics (MD) simulations, to repurpose FDA-approved drugs as potential PDE5 inhibitors...
December 7, 2023: ChemistryOpen
https://read.qxmd.com/read/38059649/blockade-of-phosphodiesterase-5-by-sildenafil-reduces-tumor-growth-and-potentiates-tumor-killing-ability-of-cisplatin-in-vivo-against-t-cell-lymphoma-implication-of-modulated-apoptosis-reactive-oxygen-species-homeostasis-glucose-metabolism-and-ph-regulation
#44
JOURNAL ARTICLE
Shiv Govind Rawat, Rajan Kumar Tiwari, Ajay Kumar
In the past years, PDE5 has emerged as a promising therapeutic target for many cancers due to its highly upregulated expression. Interestingly, a recent in vitro study by our group has shown the antitumor and chemopotentiating action of sildenafil against T cell lymphoma. Our study showed that lower doses of sildenafil (50 μM) and cisplatin (0.5 μg/mL) exhibited 4% and 23% cytotoxicity against HuT78 cells, respectively, which was dramatically increased up to 50% when treated with both...
December 7, 2023: Environmental Toxicology
https://read.qxmd.com/read/38034900/efficacy-of-chinese-herbal-medicine-formula-in-the-treatment-of-mild-to-moderate-erectile-dysfunction-study-protocol-for-a-multi-center-randomized-double-blinded-placebo-controlled-clinical-trial
#45
JOURNAL ARTICLE
Run-Nan Xu, Jian-Xiong Ma, Xin Zhang, Ze-Dong Liao, Yi-Jia Fu, Bo-Dong Lv
INTRODUCTION: Erectile dysfunction (ED) is a prevalent condition in urology, primarily managed with PDE5 inhibitors (PDE5Is). However, approximately 20% of patients do not experience improvement in overall sexual satisfaction (OS) after taking PDE5Is. Among these, traditional Chinese medicine (TCM) has emerged as a complementary approach, with formulas like Hongjing I granules (HJIG) showing promise in preliminary studies. This study aims to rigorously evaluate the effectiveness and safety of HJIG in mild to moderate ED cases, assessing improvement in both sexual function and TCM pattern alignment...
2023: International Journal of General Medicine
https://read.qxmd.com/read/38034088/safety-profile-and-signal-detection-of-phosphodiesterase-type-5-inhibitors-for-erectile-dysfunction-a-food-and-drug-administration-adverse-event-reporting-system-analysis
#46
JOURNAL ARTICLE
Young Eun Shin, Sirikan Rojanasarot, Ana L Hincapie, Jeff Jianfei Guo
BACKGROUND: Phosphodiesterase type 5 inhibitors (PDE5Is) are generally well tolerated but have been associated with uncommon and significant adverse events (AEs). AIM: This study aims to investigate and compare the characteristics of AEs associated with PDE5Is used for erectile dysfunction and identify any safety signals in a postmarketing surveillance database between 2010 and 2021. METHODS: A descriptive analysis was conducted for all AEs reported to the Food and Drug Administration Adverse Event Reporting System for 4 PDE5Is-avanafil, sildenafil, tadalafil, and vardenafil-indicated for erectile dysfunction between January 2010 and December 2021...
October 2023: Sexual Medicine
https://read.qxmd.com/read/38033148/unmasking-hidden-risks-the-surprising-link-between-pde5-inhibitors-and-seizure-susceptibility
#47
JOURNAL ARTICLE
Alex Luiz Menezes da Silva, Chirlene Pinheiro Nascimento, Julianne Elba Cunha Azevedo, Luana Rodrigues Vieira, Akira Otake Hamoy, Allan Carlos da Silva Tiago, João Cleiton Martins Rodrigues, Daniella Bastos de Araujo, Dielly Catrina Favacho Lopes, Vanessa Jóia de Mello, Moisés Hamoy
BACKGROUND: Phosphodiesterase 5 inhibitors (PDE5i) are the first line treatment for erectile dysfunction; however, several articles and case reports have shown central nervous system effects, that can cause seizures in susceptible patients. This study aims to describe the changes caused by the use of Sildenafil and Tadalafil through the analysis of abnormalities expressed in the electrocorticogram (ECoG) of rats and evaluate the seizure threshold response and treatment of seizures with anticonvulsants...
2023: PloS One
https://read.qxmd.com/read/38032134/postmicturition-dribble-in-men-with-no-previous-urogenital-surgery-systematic-review-and-meta-analysis-of-treatment-modalities
#48
REVIEW
Ahmed Albakr, Walid El Ansari, Mohammed Mahdi, Heba Megahed, Merilyn Lock, Mohamed Arafa, Hanaa Al Hothi, Ardalan Ghafouri
INTRODUCTION: Postmicturition dribble (PMD) is common in males. Little is known about PMD etiology, but it is either secondary to urethral/prostatic surgery or primary (no previous surgery). Despite PMD's high prevalence, the effectiveness of its treatment modalities remains lacking. OBJECTIVE: To undertake a systematic review of the available treatments for primary PMD in adult males and meta-analysis of their effectiveness. MATERIALS AND METHODS: We searched four electronic databases from inception to 2023 for original articles that evaluated PMD treatments in male adults without previous urethral/prostatic surgery (PROSPERO protocol CRD42023444591)...
November 30, 2023: Neurourology and Urodynamics
https://read.qxmd.com/read/38030140/pde5-inhibition-reduced-blood-pressure-and-alleviated-target-organ-damage-in-chronic-intermittent-hypoxia
#49
JOURNAL ARTICLE
Siyi Li, Qingjie Xin, Yan Yan, Xiao Wang, Hui Ai, Bin Que, Wei Gong, Shaoping Nie
The role of phosphodiesterase 5 (Pde5) in obstructive sleep apnea (OSA) induced damage remains unclear. Our study aimed to investigate the role of Pde5 in chronic intermittent hypoxia (CIH) model. C57BL/6J wild-type (WT) mice (n=48) and Pde5 knockout (Pde5-/-) mice (n=24) were randomly assigned to CIH group and room air (RA) group. After 6 weeks, some WT mice (n=24) in CIH group were given sildenafil or saline gavage for another 4 weeks. Blood pressure was regularly measured during the experiment. Echocardiography was used to estimate cardiac function...
November 23, 2023: Journal of Cardiovascular Pharmacology
https://read.qxmd.com/read/38025082/promising-derivatives-of-rutaecarpine-with-diverse-pharmacological-activities
#50
REVIEW
Deping Li, Ziqian Huang, Xiaojun Xu, Yan Li
Rutaecarpine (RUT) is a natural pentacyclic indolopyridoquinazolinone alkaloid first isolated from one of the most famous traditional Chinese herbs, Evodia rutaecarpa , which is used for treating a variety of ailments, including headaches, gastrointestinal disorders, postpartum hemorrhage, amenorrhea, difficult menstruation, and other diseases. Accumulating pharmacological studies showed that RUT possesses a wide range of pharmacological effects through different mechanisms. However, its poor physicochemical properties and moderate biological activities have hampered its clinical application...
2023: Frontiers in Chemistry
https://read.qxmd.com/read/38019570/identification-of-emotional-spectrums-of-patients-taking-an-erectile-dysfunction-medication-ontology-based-emotion-analysis-of-patient-medication-reviews-on-social-media
#51
JOURNAL ARTICLE
Youran Noh, Maryanne Kim, Song Hee Hong
BACKGROUND: Patient medication reviews on social networking sites provide valuable insights into the experiences and sentiments of individuals taking specific medications. Understanding the emotional spectrum expressed by patients can shed light on their overall satisfaction with medication treatment. This study aims to explore the emotions expressed by patients taking phosphodiesterase type 5 (PDE5) inhibitors and their impact on sentiment. OBJECTIVE: This study aimed to (1) identify the distribution of 6 Parrot emotions in patient medication reviews across different patient characteristics and PDE5 inhibitors, (2) determine the relative impact of each emotion on the overall sentiment derived from the language expressed in each patient medication review while controlling for different patient characteristics and PDE5 inhibitors, and (3) assess the predictive power of the overall sentiment in explaining patient satisfaction with medication treatment...
November 29, 2023: Journal of Medical Internet Research
https://read.qxmd.com/read/37982667/the-relationship-between-the-history-of-pde5-inhibitors-assumption-and-melanoma-a-systematic-review
#52
REVIEW
Simone Cilio, Giulia Briatico, Gabriella Brancaccio, Federico Capone, Matteo Ferro, Ciro Imbimbo, Andrea Salonia, Giuseppe Argenziano, Felice Crocetto
INTRODUCTION: Phosphodiesterase 5 inhibitors (PDE5-is) are used worldwide as first line therapy for erectile dysfunction (ED). Current literature reported data on the warning association between PDE5-is use and the development of cutaneous melanoma. However, these data are contrasting, thus we aim to summarise evidence regarding this association. CONTENT: A systematic review of all published articles related to the effects of PDE5-is in the development of cutaneous melanoma was performed...
November 21, 2023: Journal of Basic and Clinical Physiology and Pharmacology
https://read.qxmd.com/read/37981232/breast-cancer-resistance-protein-limits-fetal-transfer-of-tadalafil-in-mice-bcrp-limits-fetal-transfer-of-tadalafil
#53
JOURNAL ARTICLE
Tomohiro Nishimura, Mari Ishii, Hiroaki Tanaka, Saki Noguchi, Tomoaki Ikeda, Masatoshi Tomi
Tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, is a candidate therapeutic agent for fetal growth restriction and hypertensive disorders of pregnancy. In this study, we elucidated the fetal transfer of tadalafil in comparison with that of sildenafil, the first PDE5 inhibitor to be approved. We also examined the contributions of multidrug resistance protein 1 (MDR1) and breast cancer resistance protein (BCRP) to fetal transfer. Tadalafil or sildenafil was administered to wild-type, Mdr1a/b-double-knockout or Bcrp-knockout pregnant mice by continuous infusion from gestational day (GD) 14...
November 17, 2023: Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/37974314/-pentaclethra-macrophylla-leaves-reduce-blood-glucose-level-improve-sexual-behavior-and-modulate-critical-enzymes-associated-with-diabetes-erectile-dysfunction-morbidity-in-rats
#54
JOURNAL ARTICLE
Onyinyechi Ruth Nwagwe, Stephen Adeniyi Adefegha, Ganiyu Oboh
OBJECTIVES: This research work studied the phenolic composition of Pentaclethra macrophylla (PM), the inclusion of dietary supplementation of PM leaves on sexual functions and its connection to inhibit enzymes (arginase and phosphodiesterase-5) and nitric oxide level, linked to type 2 diabetes-induced erectile dysfunction in rats. METHODS: Gallic acid, chlorogenic and ellagic acids, Kaempferol, and epicatechin etc. was spotted with High performance liquid chromatography-diode array detector from PM extract...
November 17, 2023: Journal of Complementary & Integrative Medicine
https://read.qxmd.com/read/37973393/erectile-response-profiles-of-men-using-pde5-inhibitors-combined-with-intracavernosal-injections-as-part-of-a-penile-rehabilitation-program-after-radical-prostatectomy
#55
JOURNAL ARTICLE
Thiago P Furtado, Eduardo P Miranda, Serkan Deveci, Lawrence Jenkins, Joseph Narus, Christian Nelson, John P Mulhall
BACKGROUND: Phosphodiesterase type 5 (PDE5) inhibitor labeling states that these agents should not be used in conjunction with other erectogenic medications for fear of priapism occurring. AIM: We explored the risk of priapism and prolonged erections in men in our post-radical prostatectomy (RP) penile injection program who were using regular PDE5 inhibitor and intracavernosal injections (ICIs) as part of their rehabilitation program. METHODS: The study cohort included men on penile injection therapy who (1) were taking tadalafil 5 mg daily or taking sildenafil 25 mg on noninjection days, (2) had an RP, (3) were using their respective PDE5 inhibitor regularly at the time of penile injection training, and (4) complied with the program instructions regarding penile injection use...
December 22, 2023: Journal of Sexual Medicine
https://read.qxmd.com/read/37963482/-pulmonary-hypertension-associated-with-left-heart-disease-group-2
#56
JOURNAL ARTICLE
Kai Helge Schmidt, Olympia Bikou, Rüdiger Blindt, Leonhard Bruch, Ralf Felgendreher, Wolfgang Hohenforst-Schmidt, Stephan Holt, Dennis Ladage, Elena Pfeuffer-Jovic, Andreas Rieth, Alexander Schmeisser, Katharina Schnitzler, Stefan Stadler, Regina Steringer-Mascherbauer, Athiththan Yogeswaran, Wolfgang M Kuebler
Pulmonary hypertension associated with left heart disease (PH-LHD) corresponds to group two of pulmonary hypertension according to clinical classification. Haemodynamically, this group includes isolated post-capillary pulmonary hypertension (IpcPH) and combined post- and pre-capillary pulmonary hypertension (CpcPH). PH-LHD is defined by an mPAP > 20 mmHg and a PAWP > 15 mmHg, pulmonary vascular resistance (PVR) with a cut-off value of 2 Wood Units (WU) is used to differentiate between IpcPH and CpcPH...
November 2023: Pneumologie
https://read.qxmd.com/read/37957534/vardenafil-alleviates-cigarette-smoke-induced-chronic-obstructive-pulmonary-disease-by-activating-autophagy-via-the-ampk-mtor-signalling-pathway-an-in-vitro-and-in-vivo-study
#57
JOURNAL ARTICLE
Weihao Li, Jingxia Yan, Jing Xu, Liqin Zhu, Cuijuan Zhai, Yajuan Wang, Yuxin Wang, Ying Feng, Huifang Cao
Chronic obstructive pulmonary disease (COPD) has always attracted global attention with its high prevalence, incidence rate, and mortality. Exposure to cigarette smoke is one of main causes of COPD. Therefore, it is still necessary to study its pathogenesis and find new therapeutic strategies for early COPD prevention and treatment. Vardenafil, a type 5 phosphodiesterase (PDE5) inhibitor, is known to have an efficient therapy in some cardiovascular, pulmonary, and vascular diseases, which is an important mechanism for COPD...
November 13, 2023: In Vitro Cellular & Developmental Biology. Animal
https://read.qxmd.com/read/37951363/a-cost-analysis-of-phosphodiesterase-type-5-inhibitors-in-the-united-states
#58
JOURNAL ARTICLE
Behnam Nabavizadeh, Amanda Nguyen, Diane Li, Jeroen van Meijgaard, Benjamin N Breyer
OBJECTIVE: To perform a cost analysis of generic and brand-name PDE5 inhibitors at different dosages and pharmacies across the US. METHODS: Using an all-payer retail pharmacy-claims database, we analyzed prescription drug data for three generic and six brand-name oral PDE5 inhibitors at different dosages across US chain and independent pharmacies in 2019. RESULTS: We obtained cash price data from 60,186 pharmacies (35,976 chain and 24,210 independent)...
November 9, 2023: Urology
https://read.qxmd.com/read/37938242/antioxidant-activity-of-flemingia-praecox-and-mucuna-pruriens-and-their-implications-for-male-fertility-improvement
#59
JOURNAL ARTICLE
Shravan D Kumbhare, Sanghadeep S Ukey, Dayanand P Gogle
Globally, 15-24% couples are unable to conceive naturally and 50% of cases of this problem are due to infertility in males. Of this, about 50% of male infertility problems are developed due to unknown reasons called as idiopathic infertility. It is well established that, reactive oxygen species (ROS) have negative impact on male fertility and are involved in 80% of total idiopathic male infertility cases. Medicinal plants are considered as an alternative approach for mitigating the health problems. The plants with good antioxidant capacity can improve the male infertility symptoms generated by ROS...
November 8, 2023: Scientific Reports
https://read.qxmd.com/read/37929840/phosphodiesterase-5-inhibitors-pde5i-for-the-treatment-of-raynaud-s-phenomenon
#60
REVIEW
Nancy Maltez, Lara J Maxwell, Fadumo Rirash, Elizabeth Tanjong Ghogomu, Sarah E Harding, Paul C Tingey, George A Wells, Peter Tugwell, Janet Pope
BACKGROUND: Raynaud's phenomenon is a vasodilatory phenomenon characterised by digital pallor, cyanosis, and pain of the extremities. Primary Raynaud's phenomenon has no underlying disease associated with it, while secondary Raynaud's phenomenon is associated with connective tissue disorders such as systemic sclerosis. Systemic sclerosis causes fibrosis and commonly affects the skin and internal organs such as the gastrointestinal tract, lungs, kidney, and heart. Phosphodiesterase 5 inhibitors (PDE5i) are a class of drugs that increases blood flow to the extremities and may be beneficial in the treatment of Raynaud's phenomenon...
November 6, 2023: Cochrane Database of Systematic Reviews
keyword
keyword
93300
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.